NCT04405167 2025-10-07
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
University of Pennsylvania
Phase 1 Terminated
Clinical Trials
4 trialsNCT02159950 2023-04-27
Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT01513733 2018-09-04
CATCH
Duke University
Phase 1 Completed
NCT02396368 2015-11-20
Radium-223
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Withdrawn